Related Experiment Video
Updated: Nov 23, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-141-3p regulates cellular proliferation, migration, and invasion in esophageal cancer by targeting tuberous
Pornima Phatak1,2,3, Michael Noe4, Kaushal Asrani4
1Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA.
Abstract:
MicroRNA (miR)-141-3p, which functions as an oncogene in multiple malignancies, has been shown to be highly overexpressed in esophageal cancer cells in our previous work. miR-141-3p is predicted to bind the messenger RNA (mRNA) of tuberous sclerosis complex 1 (TSC1), a tumor suppressor, with high affinity. In this study, we investigated the expression and functional interaction between miR-141-3p and TSC1 in esophageal cancer cells. Experiments were conducted in four esophageal cancer lines and in tumor cells isolated from human esophageal cancer specimens by laser capture microdissection. miR-141-3p expression was measured by real time and droplet digital PCR. Biotinylated RNA pull-down and luciferase reporter assays were used to assess binding. miR-141-3p function was tested by assessing proliferation, migration, invasion, and induction of autophagy following its silencing. We found that miR-141-3p levels were increased in TE7, OE33, and TE10 esophageal cancer cells compared to FLO-1 cells, with similar heterogeneity observed in human esophageal cancer specimens. Silencing of miR-141-3p led to increased TSC1 protein expression in these cells and was associated with increased TSC1 translation. Binding studies reveal that miR-141-3p binds to each of the predicted binding sites in the 3'-untranslated region of TSC1 mRNA. Following miR-141-3p silencing, TE7, OE33, and TE10 cells exhibited decreased proliferation, migration, and invasion, as well as enhanced autophagy. Importantly, these phenotypic effects were replicated by overexpression of TSC1 alone in these cells. Our results indicate that miR-141-3p functions in an oncogenic capacity in a subset of esophageal cancer cells, in part by suppressing TSC1 expression.
Insights
MicroRNA-141-3p acts as an oncogene in esophageal cancer by suppressing the tumor suppressor TSC1. Silencing this microRNA reduced cancer cell growth and spread, offering a potential therapeutic target.
Area of Science:
- Molecular Oncology
- Cancer Biology
Background:
- MicroRNA (miR)-141-3p is an oncogene overexpressed in esophageal cancer.
- Tuberous sclerosis complex 1 (TSC1) is a tumor suppressor potentially targeted by miR-141-3p.
Purpose of the Study:
- Investigate the expression and functional interaction between miR-141-3p and TSC1 in esophageal cancer cells.
- Determine the oncogenic role of miR-141-3p in esophageal cancer.
Main Methods:
- Real-time and droplet digital PCR for miR-141-3p expression.
- Biotinylated RNA pull-down and luciferase reporter assays for binding confirmation.
- Cell proliferation, migration, invasion, and autophagy assays after miR-141-3p silencing.
Main Results:
- miR-141-3p was elevated in specific esophageal cancer cell lines and patient specimens.
- Silencing miR-141-3p increased TSC1 protein expression and translation.
- miR-141-3p directly binds to TSC1 mRNA, inhibiting its expression.
- Reduced proliferation, migration, and invasion, with enhanced autophagy observed upon miR-141-3p silencing.
Conclusions:
- miR-141-3p promotes esophageal cancer progression by suppressing TSC1.
- The miR-141-3p/TSC1 axis is a potential therapeutic target in a subset of esophageal cancers.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Destabilization of Microtubules

